A comparative analysis of phyto-components on EGFR binding, viability, and migration in HPV positive ME180 and HPV negative C33A cervical cancer cells

Med Oncol. 2023 Nov 14;40(12):357. doi: 10.1007/s12032-023-02223-2.

Abstract

A need for effective implementation of cervical cancer (CC) even in developed countries insist the urge for developing an effective drug molecule to treat CC. Previously, we showed an inverse correlation between survival of CC patients and epidermal growth factor (EGF) receptor (EGFR) levels. Newer tyrosine kinase inhibitors to treat CC are being constantly pursued. In this context, the proposed study is an attempt to perform a comparative analysis using 20 phyto-components to determine the effective lead molecule. Molecular docking was utilized to determine the comparative efficacy of 20 phyto-components in binding to EGFR. It was then validated by cell viability, mitochondrial membrane potential, apoptosis, migration, and matrix metalloproteinase (MMP-2) in human papilloma virus (HPV) positive and HPV negative CC cells using top nine phyto-components based on computational screening. Computational analysis identified nine phyto-components out of which five compounds were effective in reducing the survival, mitochondrial membrane potential, apoptosis, migration, and MMP-2 secretion. EGCG, plumbagin, quercetin, emodin, and naringenin were identified as effective molecules in attenuating CC survival, proliferation, and migration.

Keywords: C33A; EGFR; HPV; ME180; Migration; Phyto-components.

MeSH terms

  • ErbB Receptors / metabolism
  • Female
  • Humans
  • Matrix Metalloproteinase 2
  • Molecular Docking Simulation
  • Papillomavirus Infections* / drug therapy
  • Uterine Cervical Neoplasms* / drug therapy

Substances

  • Matrix Metalloproteinase 2
  • ErbB Receptors
  • EGFR protein, human